DOLIAM is a French family-owned industrial group that invests in, supports, and actively partners with innovative MedTech and DeepTech startups and companies. These ventures are developing tomorrow’s groundbreaking solutions today through truly disruptive technologies.

Deeply rooted in the high-tech ecosystem, DOLIAM has established itself as a recognized leader in the industry through a cohesive portfolio of subsidiaries and strategic investments. The group covers the whole innovation value chain, from high-performance printed circuit board design with PCB-CONCEPT, advanced energy optimization solutions developed by VITRUVENS, next-generation medical imaging and cardiac stimulation technologies pioneered by VERMON, MODULEUS, and CAIRDAC, and cutting-edge protection systems for people and critical assets created by OLYTHE.

Beyond its core subsidiaries, DOLIAM pursues an active investment strategy in high-potential startups, including FINEHEART with its breakthrough wireless cardiac pump for the treatment of severe heart failure, ICONEUS and its pioneering ultrasound-based neurofunctional imaging system, and INJECTPOWER, which is developing the next generation of microbatteries and energy storage systems for active implantable medical devices.

Through this long-term investment and hands-on support approach, DOLIAM plays a key role in bringing to life the innovations that will profoundly transform medicine and industry in the years ahead.